.Merck beats earnings expectations, rears purchases expectation on powerful need for best medications like Keytruda CNBCMerck & Co. (MRK US) Defeats Earnings Estimates as Keytruda Purchases Growth BloombergMerck Supply: Pharma Titan Posts Tough Outcomes, But Expectation Tumbles Short Investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats earnings and also purchases expectations among Keytruda asset, yet provides combined full-year overview MarketWatch.